Intermediate Risk Prostate Cancer

Explore clinical trials studying Intermediate Risk Prostate Cancer. Study availability and eligibility vary by location and protocol.

5 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Intermediate Risk Prostate Cancer trial results

Recruiting

NCT07393867

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center Milford, Massachusetts, United States

Dana-Farber/Brigham and Women's Cancer Center in Clinical Affiliation with South Shore Hospital Weymouth, Massachusetts, United States

Recruiting

NCT06117059

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations: NHS Lothian Edinburgh, United Kingdom

Completed

NCT02028988

Conditions: Intermediate Risk Prostate Cancer
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Completed

NCT01379872

Conditions: Anal Cancer, Anus Diseases, Anus Neoplasms, +30 more
Locations: Royal Prince Alfred Hospital Camperdown, New South Wales, Australia

Liverpool Hospital Liverpool, New South Wales, Australia

Calvary Mater Newcastle Newcastle, New South Wales, Australia

Prince of Wales Hospital Randwick, New South Wales, Australia

View all 15 locations

Active, Not Recruiting

NCT05917860

Conditions: Castration-Naive Prostate Cancer, Genital Diseases, Genital Diseases, Male, +11 more
Locations: Turku University Hospital Turku, Southwest Finland, Finland